Regulatory Headwinds Rattle Tilray Shares

Tilray shares experienced significant downward pressure on Tuesday, declining 5.4 percent to close at $1.22. The cannabis company’s vocal opposition to newly proposed U.S. hemp restrictions within a government funding bill created uncertainty among investors, triggering the sell-off.

The market reaction comes despite Tilray’s recently reported strong operational performance. Just in October, the company announced record quarterly revenue reaching $209.5 million, alongside net income of $1.5 million. Its adjusted EBITDA showed a 9 percent improvement, climbing to $10 million.

Trading volume surged to 34.67 million shares during the session, indicating substantial investor anxiety about the regulatory developments. This contrasts sharply with the stock’s recent peak of $2.32 reached on October 9, from which Read more...